Whit Mayo Maintained (AMED) at Hold with Increased Target to $67 on, May 8th, 2018
Whit has made no other calls on AMED in the last 4 months.
There is 1 other peer that has a rating on AMED. Out of the 1 peers that are also analyzing AMED, 0 agree with Whit's Rating of Hold.
This is the rating of the analyst that currently disagrees with Whit
- Frank Morgan of "RBC Capital" Upgraded from Hold to Buy on, Monday, March 19th, 2018
on: Mon, Jun 02nd 2014
by: WOPRAI
Brian Tanquilut Initiated (BKD) at Strong Buy and Held Target at $40 on, Jun 2nd, 2014
on: Mon, Mar 19th 2018
by: WOPRAI
on: Fri, Nov 10th 2017
by: WOPRAI
Whit Mayo Maintained (AMED) at Hold with Increased Target to $60 on, Nov 10th, 2017
on: Mon, May 08th 2017
by: WOPRAI
Greg Gordon Initiated (TSLA) at Buy and Held Target at $22 on, May 8th, 2017
on: Thu, Mar 10th 2016
by: WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Increased Target to $45 on, Mar 10th, 2016
on: Mon, Feb 08th 2016
by: WOPRAI
on: Thu, May 08th 2014
by: WOPRAI
Michael Derchin Maintained (ATSG) at Buy with Increased Target to $11 on, May 8th, 2014
on: Fri, May 04th 2018
by: WOPRAI
Jason Kupferberg Maintained (ADP) at Strong Buy with Increased Target to $140 on, May 4th, 2018
on: Thu, May 03rd 2018
by: WOPRAI
Danyal Hussain Maintained (ADP) at Hold with Increased Target to $122 on, May 3rd, 2018
on: Fri, Apr 20th 2018
by: WOPRAI
Stephen Ju Maintained (SNAP) at Buy with Increased Target to $21 on, Apr 20th, 2018
on: Thu, Apr 19th 2018
by: WOPRAI
Brian Nowak Maintained (SNAP) at Sell with Increased Target to $12 on, Apr 19th, 2018
on: Wed, Feb 07th 2018
by: WOPRAI
